Driving Investment and Innovation in Life Sciences
While the world of life sciences is in a period of relentless disruption and advances in technology are transforming research and development, how are innovative treatments such as mRNA vaccines and cell therapies reshaping health care as we know it? How are companies overcoming the challenge of bringing products to market in an unsettled regulatory environment? As leaders across the pharma industry pursue growth for their companies, many disruptive forces are compelling them to radically transform business models. Technology and innovation are creating new avenues for growth, but the risks of investment are high. How are relations between pharma companies, suppliers, regulators, payers, doctors and patients evolving? Deloitte leaders, along with industry peers, will unpack many of these critical questions and more at this year’s conference.
Deloitte is proud to once again be a strategic sponsor and is pleased to offer a discounted registration to this year’s conference